Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be ...

To answer this, researchers from Karolinska Institutet and Charles University studied a genetic disease called Alagille ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

An international study has identified two types of these so-called dysbioses in cystic fibrosis. They display ... Landmark Study Involving Babies in Ireland Supports Use of Cystic Fibrosis Drug in ...

Lobular inflammation: polymorphonuclear cells in association with ballooned hepatocytes; pericellular fibrosis; mild chronic inflammation may be seen. Portal inflammation: mild to moderate.

In a small Phase IIa trial, Insilico’s generative AI-designed idiopathic pulmonary fibrosis drug improved lung function and ...

Fibrosis was absent in 27.5% of cases, mild in 55% and moderate in 16.2%. Only 1.3% (one of the 80 children) had cirrhosis. A significant relationship was detected between fibrosis scores and ...

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options ...

Insilico Medicine plans to push its computer-designed drug into pivotal clinical trials after a phase 2a study demonstrated ...

Accumulation of extracellular matrix (ECM) in liver fibrosis is associated with changes in protein abundance and composition depending upon etiology of the underlying liver disease. Current efforts to ...

and moderate to advanced liver fibrosis (stage 2 or 3) 1. Part 1 of the ESSENCE trial evaluated the effect of once-weekly semaglutide 2.4 mg on liver tissue (histology) compared to placebo on top ...